These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25341891)

  • 1. Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.
    Chahine MN; Mioulane M; Sikkel MB; O'Gara P; Dos Remedios CG; Pierce GN; Lyon AR; Földes G; Harding SE
    Cardiovasc Res; 2015 Jan; 105(1):31-43. PubMed ID: 25341891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure.
    Ljubojevic S; Radulovic S; Leitinger G; Sedej S; Sacherer M; Holzer M; Winkler C; Pritz E; Mittler T; Schmidt A; Sereinigg M; Wakula P; Zissimopoulos S; Bisping E; Post H; Marsche G; Bossuyt J; Bers DM; Kockskämper J; Pieske B
    Circulation; 2014 Jul; 130(3):244-55. PubMed ID: 24928680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform- and tissue-specific regulation of the Ca(2+)-sensitive transcription factor NFAT in cardiac myocytes and heart failure.
    Rinne A; Kapur N; Molkentin JD; Pogwizd SM; Bers DM; Banach K; Blatter LA
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2001-9. PubMed ID: 20304816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKIIδC Drives Early Adaptive Ca
    Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
    Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
    Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Salvador A; Rivera M
    Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRM1 nuclear export receptor controls pathological cardiac gene expression.
    Harrison BC; Roberts CR; Hood DB; Sweeney M; Gould JM; Bush EW; McKinsey TA
    Mol Cell Biol; 2004 Dec; 24(24):10636-49. PubMed ID: 15572669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein.
    Boateng SY; Senyo SE; Qi L; Goldspink PH; Russell B
    J Mol Cell Cardiol; 2009 Oct; 47(4):426-35. PubMed ID: 19376126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy.
    Oceandy D; Pickard A; Prehar S; Zi M; Mohamed TM; Stanley PJ; Baudoin-Stanley F; Nadif R; Tommasi S; Pfeifer GP; Armesilla AL; Cartwright EJ; Neyses L
    Circulation; 2009 Aug; 120(7):607-16. PubMed ID: 19652091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy.
    Hallhuber M; Burkard N; Wu R; Buch MH; Engelhardt S; Hein L; Neyses L; Schuh K; Ritter O
    Circ Res; 2006 Sep; 99(6):626-35. PubMed ID: 16931796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling.
    Lehmann LH; Rostosky JS; Buss SJ; Kreusser MM; Krebs J; Mier W; Enseleit F; Spiger K; Hardt SE; Wieland T; Haass M; Lüscher TF; Schneider MD; Parlato R; Gröne HJ; Haberkorn U; Yanagisawa M; Katus HA; Backs J
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13499-504. PubMed ID: 25197047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
    Oda T; Yamamoto T; Kato T; Uchinoumi H; Fukui G; Hamada Y; Nanno T; Ishiguchi H; Nakamura Y; Okamoto Y; Kono M; Okuda S; Kobayashi S; Bers DM; Yano M
    J Mol Cell Cardiol; 2018 Dec; 125():87-97. PubMed ID: 30359562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1.
    Monovich L; Koch KA; Burgis R; Osimboni E; Mann T; Wall D; Gao J; Feng Y; Vega RB; Turner BA; Hood DB; Law A; Papst PJ; Koditek D; Chapo JA; Reid BG; Melvin LS; Pagratis NC; McKinsey TA
    Biochim Biophys Acta; 2009 May; 1789(5):422-31. PubMed ID: 19414071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure.
    Walther S; Awad S; Lonchyna VA; Blatter LA
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H856-66. PubMed ID: 24441548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
    Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
    Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.
    Slone S; Anthony SR; Wu X; Benoit JB; Aube J; Xu L; Tranter M
    Cell Signal; 2016 Nov; 28(11):1735-41. PubMed ID: 27521603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.